Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.

Duran G, Aguín S, Cruz R, Barros F, Giráldez JM, Bernárdez B, López-López R, Carracedo Á, Lamas MJ.

Head Neck. 2019 Aug;41(8):2704-2715. doi: 10.1002/hed.25754. Epub 2019 Apr 11.

PMID:
30973677
2.

Evaluation of Circulating Tumor Cells and Related Events as Prognostic Factors and Surrogate Biomarkers in Advanced NSCLC Patients Receiving First-Line Systemic Treatment.

Muinelo-Romay L, Vieito M, Abalo A, Nocelo MA, Barón F, Anido U, Brozos E, Vázquez F, Aguín S, Abal M, López RL.

Cancers (Basel). 2014 Jan 21;6(1):153-65. doi: 10.3390/cancers6010153.

3.

Zoledronic acid as an antimetastatic agent for different human tumor cell lines.

Muinelo-Romay L, Garcia D, Alonso-Alconada L, Vieito M, Carmona M, Martínez N, Aguín S, Abal M, López-López R.

Anticancer Res. 2013 Dec;33(12):5295-300.

PMID:
24324062

Supplemental Content

Loading ...
Support Center